Meeting
2018 ASCO Annual Meeting
Retroperitoneal cancer viability after postchemotherapy retroperitoneal lymph node dissection (PC-RPLND) in good risk germ cell tumors (GCTs).
Authors
Fadi Taza
Division of Hematology and Oncology, Indiana University Simon Cancer Center, Indianapolis, IN
Fadi Taza , Michal Chovanec , Anna Snavely , Nabil Adra , Nasser H. Hanna , Clint Cary , Timothy A. Masterson , Lawrence H. Einhorn , Costantine Albany
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Genitourinary (Nonprostate) Cancer
Track
Genitourinary Cancer—Kidney and Bladder
Sub Track
Germ Cell/Testicular
Citation
J Clin Oncol 36, 2018 (suppl; abstr 4551)
DOI
10.1200/JCO.2018.36.15_suppl.4551
Abstract #
4551
Poster Bd #
377
Abstract Disclosures
Similar Posters
Poster
2014 ASCO Annual Meeting
Survival of good-risk germ cell tumor patients following post-chemotherapy retroperitoneal lymph node dissection: The effect of bleomycin during induction chemotherapy.
First Author: K. Clint Cary
Poster
2018 ASCO Annual Meeting
Etoposide and cisplatin (EP) for metastatic good-risk germ cell tumors (GCTs): The Memorial Sloan-Kettering Cancer Center (MSKCC) experience in 944 patients (pts).
First Author: Samuel Funt
Poster
2024 ASCO Genitourinary Cancers Symposium
North American patterns of care in clinical stage I testicular cancer from SWOG S1823.
First Author: Antoine Morin Coulombe
Poster
2023 ASCO Annual Meeting
The impact of adjuvant platinum-based chemotherapy in early adult granulosa cell tumor of the ovaries: A meta-analysis of comparative studies.
First Author: Dinesh Keerty